Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome
2004 · Breast Cancer Research · 855 citations
https://doi.org/10.1186/bcr767
R
Richard Elledge
The University of Texas Health Science Center at San Antonio(US)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
129
Papers
13.7K
Citations
53
h-index
88
i10-index
Richard Elledge is an academic researcher from The University of Texas Health Science Center at San Antonio. The author has contributed to research in topics: Breast Cancer Treatment Studies & Estrogen and related hormone effects & HER2/EGFR in Cancer Research. The author has an h-index of 53, co-authored 110 publications.
Papers by this author
worksEstrogen Receptor–Positive, Progesterone Receptor–Negative Breast Cancer: Association With Growth Factor Receptor Expression and Tamoxifen Resistance
2005 · JNCI Journal of the National Cancer Institute · 484 citations
https://doi.org/10.1093/jnci/dji249
Tumor Biologic Factors and Breast Cancer Prognosis Among White, Hispanic, and Black Women in the United States
1994 · JNCI Journal of the National Cancer Institute · 417 citations
https://doi.org/10.1093/jnci/86.9.705
HER-2 expression and response to tamoxifen in estrogen receptor-positive breast cancer: a Southwest Oncology Group Study.
1998 · PubMed · 266 citations
Clinical and biologic features of triple-negative breast cancers in a large cohort of patients with long-term follow-up
2012 · Breast Cancer Research and Treatment · 262 citations
https://doi.org/10.1007/s10549-012-2315-y
Neoadjuvant Trastuzumab Induces Apoptosis in Primary Breast Cancers
2005 · Journal of Clinical Oncology · 243 citations
https://doi.org/10.1200/jco.2005.00.661
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat